Month: September 2008

Invitrogen and Biocare to Market Breast Cancer Test

Invitrogen Corp, Carlsbad, Calif, a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive US distribution agreement with Biocare Medical LLC, for the new SPOT-Light HER2 CISH Kit. The kit received US Food and Drug Administration premarket approval in July, as an aid in the assessment of breast cancer patients for whom trastuzumab (Herceptin) treatment is being considered.

Read More